Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Umer Raffat
Pharma
Analysts to Gilead CEO: What's your plan to monetize remdesivir?
Just a day after remdesivir posted positive data, analysts hounded Gilead's CEO with one key question: When will the drug start making money?
Carly Helfand
Apr 30, 2020 8:28pm
Allergan preparing to split after years of turmoil: analyst
Jun 19, 2019 10:50am
BMS-Celgene integration questions? Execs aren't answering
Apr 26, 2019 11:45am
'Old guard' generics players yield U.S. scripts lead
Apr 18, 2019 12:06pm
Already delayed in lung cancer, BMS pulls crucial Opdivo filing
Jan 24, 2019 12:24pm
Pfizer, Merck topped the Dow in 2018 despite biopharma declines
Jan 2, 2019 11:33am